CHEMBIO DIAGNOSTIC SYSTEMS INC.
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $10 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Alere, Inc. (formerly, Inverness Medical Innovations, Inc.). Chembio markets its HIV STAT-PAK® line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented poin... t-of-care test platform technology, the Dual Path Platform (DPP®) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP®. Headquartered in Medford, NY, with approximately 170 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.
CHEMBIO DIAGNOSTIC SYSTEMS INC.
Industry:
Biotechnology Government Health Care Health Diagnostics Manufacturing
Founded:
1986-01-01
Address:
Medford, New York, United States
Country:
United States
Website Url:
http://www.chembio.com
Total Employee:
51+
Status:
Active
Contact:
631-924-1135
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Anika Therapeutics
Anika Therapeutics, Inc. develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its
Diagnostic Hybrids
Diagnostic Hybrids develops, manufactures, and markets cellular and molecular diagnostic kits for various applications.
Home Diagnostics
Home Diagnostics is a developer, manufacturer and marketer of blood glucose monitoring systems and disposable supplies for diabetics.
Medtronic
Medtronic develops and manufactures medical device technologies and therapies to treat chronic diseases worldwide.
Quantason
Quantason develops bi-modal US/IDUSâ„¢ platform technology for diagnostic imaging and active screening.
Quinton Cardiology Systems
Quinton Cardiology Systems develop, manufacture, market and service a family of diagnostic systems.
Current Advisors List
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-11-04 | RVR Diagnostics | RVR Diagnostics acquired by Chembio Diagnostic Systems Inc. | N/A |
Official Site Inspections
http://www.chembio.com Semrush global rank: 2.6 M Semrush visits lastest month: 6.71 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Chembio Diagnostic Systems Inc."
About us - Chembio Diagnostics, Inc.
To develop and commercialize rapid, easy to use, and reliable point of care tests that improve diagnosis and monitoring of disease.See details»
Chembio Company Profile - Office Locations, Competitors ... - Craft
Chembio $49.52 m in annual revenue in FY 2022. See insights on Chembio including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Chembio Diagnostic 2025 Company Profile: Valuation, …
Information on acquisition, funding, investors, and executives for Chembio Diagnostic. Use the PitchBook Platform to explore the full profile.See details»
Chembio Diagnostics
Feb 25, 2025 Chembio Diagnostics, Inc. was founded in 1987 and is headquartered in Medford, NY. The company develops, manufactures, licenses, and commercializes point-of-care (POC) …See details»
Chembio - 2025 Company Profile & Team - Tracxn
Aug 5, 2025 Explore Chembio's in-depth company profile, including funding details, key investors, leadership, competitors, and acquisitions.See details»
Chembio Diagnostics, Inc. - Executive Bio, Top Executies, and ...
Chembio Diagnostics, Inc. and its subsidiaries develop and commercialize point-of-care tests used to detect and diagnose infectious diseases, including sexually transmitted disease, insect …See details»
ChemBio Diagnostics Systems, Inc. | Devex
Learn more about ChemBio Diagnostics Systems, Inc.'s jobs, projects, latest news, contact information and geographical presence. They enable longer and healthier living through …See details»
Chembio Diagnostics, Inc. Information - RocketReach
Chembio Diagnostics, Inc. is a Hospital & Health Care, Pharmaceuticals, and Biotechnology company located in Hauppauge, New York with $57.9 million in revenue and 133 employees. …See details»
Our Team - Chembio Diagnostics, Inc.
Javan Esfandiari joined Chembio Diagnostic Systems, Inc. in February 2000, and serves as President of Chembio Diagnostic Biosynex Group since February 2024. Mr. Esfandiari has over 30 years of experience in Research and Development, …See details»
Chembio Diagnostic Systems Inc. - Crunchbase
Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic.See details»
Chembio Diagnostics - Overview, News & Similar companies
Jul 11, 2023 View Chembio Diagnostics (www.chembio.com) location in New York, United States , revenue, industry and description. Find related and similar companies as well as …See details»
Chembio Diagnostics, Inc. - LinkedIn
About Chembio Diagnostics: Chembio is a leading point-of-care diagnostics company focused on creating fast actionable tests to diagnose diseases quickly and accurately, including STIs and …See details»
Chembio Diagnostics, Inc. Company Overview, Contact Details ...
Learn more about Chembio Diagnostics, Inc.'s company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
Biosynex Completes Acquisition of Chembio Diagnostics, Inc.
Apr 27, 2023 Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE NEWSWIRE) …See details»
Chembio Diagnostics - Leadership Team | The Org
The Leadership Team at Chembio Diagnostics is responsible for guiding the strategic direction of the company, overseeing financial management, and ensuring compliance with quality and …See details»
Biosynex Completes Acquisition of Chembio Diagnostics,
Apr 27, 2023 Chembio Diagnostics, Inc. becomes the first North American structure controlled by Biosynex in North America STRASBOURG, France, April 27, 2023 (GLOBE...See details»
Corporate Governance - Chembio Diagnostics, Inc.
Chembio Diagnostic Systems, Inc. 3661 Horseblock Rd. Medford, NY 11763 +1-631-924-1135 SDS DocumentsSee details»
Products - Chembio Diagnostics, Inc.
Our HIV and Syphilis rapid point-of-care tests are easy to use and ideal for the outreach setting.See details»
Newsroom - Chembio Diagnostics, Inc.
Chembio Diagnostics Inc., a subsidiary of Biosynex, receives a grant for Development of a DPP Congenital Syphilis Assay Medford N.Y USA/Strasbourg France , Oct 23, 2024 Chembio …See details»
Read your Results within Minutes!
Chembio's new HIV antibody rapid test, is easy to use, accurate, and displays results within minutes.See details»